Lobbying Activity Report

3291-4147

Organization: AbbVie Corporation
Associated registration: 6450-3291-1
Lobbying Activity date: 2020-11-17
Arranged a meeting: No
Posted date: 2020-11-23

In-house lobbyists who participated in the lobbying activity: David Link Footnote1
Denis Hello
Kevin Harrington
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, ADM
Pharmaceutical, lab and Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocate for health policy evaluation regarding the measurement of the value of public expenditures on medications with respect to patient outcomes, healthcare system sustainability and appropriation of funding for medications.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Science and Technology
Gain and maintain reimbursement of AbbVie biopharmaceutical products as per provincial reviews and as defined by Pharmacare, BC Cancer Agency, BC Centre for Excellence in HIV and AIDS, and Regional Health Authorities; emphasize the roles, value and outcomes of AbbVie biopharmaceutical products in providing benefits to patient health and contribution to the BC healthcare system.
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Denis Hello
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: